Resistance of Neisseria gonorrhoeae to antimicrobial hydrophobic agents (HAS) has been ascribed to the mtr (multiple transferable resistance) operon. This operon is composed of the mtrR gene, which encodes a transcriptional repressor (MtrR), and a three-gene complex (mtrcDE), which encodes cell envelope proteins (MtrC-MtrD-MtrE) that form an energy-dependent efflux pump. HA-hypersusceptible strains are often isolated from patients, but the genetic basis for such hypersusceptibility was heretofore unknown. The genetic basis of HA hypersusceptibility in laboratory-derived strains BR54 and BR87 was studied to learn if this trait could be linked to mutations in the mtr operon. Mutations in the mtrR gene of these strains that could be phenotypically suppressed by mutations in their mtrC or mtrD genes were identified. Thus, small deletions (4-10 bp) in the mtrC or mtrD genes of strains BR87 and BR54 that would result in the production of truncated efflux pump proteins that serve as a membrane fusion protein (MtrC) or transporter of HAS (MtrD) were found to be responsible for their HA-hypersusceptible property.
INTRODUCTION
Following the introduction of penicillin to treat gonorrhoea, strains of Neisseria gonorrhoeae expressing clinically significant levels of penicillin resistance emerged. Gonococcal clinical isolates displaying hypersusceptibility to penicillin and structurally diverse hydrophobic agents (HAS) such as drugs, dyes, detergents and host-derived compounds (fatty acids and bile salts) also arose at nearly the same time as penicillinresistant strains appeared. In one particular study, conducted in North Carolina in 1978, antibiotic-hypersusceptible strains represented upwards of 15% of all gonococcal clinical isolates (Eisenstein & Sparling, 1978) . The antibiotic-hypersusceptibility profiles of +Present address: Wellcome Trust Centre for the Epidemiology of these clinical isolates were remarkably similar to a set of laboratory-derived mutants and transformants that contained mutations in different loci termed env (envelope) . On the basis of recombination studies (Eisenstein & Sparling, 1978 ; Shafer et al., 1984) , these antibiotic-hypersusceptible clinical isolates appeared to contain mutations in one of three different env loci, but most enu mutations appeared to map at or near the env-2 locus of the laboratoryderived HA-hypersusceptible strain BR87. Although Env-mutants and transformant strains were found to be hypersusceptible to structurally diverse HAS, many also contained a phenotypically suppressed mutation, now known to be in the mtrR gene , which could confer HA resistance when introduced into wild-type strain FA19 (Maness & Sparling, 1973; Sarubbi et al., 1975 ; Shafer et al., 1984) . The biochemical basis for the Env-property of such mutants has not been resolved, although earlier studies suggested that such strains had decreased amounts of a 52 kDa outerInfectious Diseases, Department of Zoology, Oxford University, South Parks membrane protein and decreased cross-linking of their Road, Oxford OX1 3PS, UK. Abbreviations: HA, hydrophobic agent; MFP, membrane fusion protein; TX-100, Triton X-100.
The GenBank accession number for the sequence of the mtrCgene of strain BR87 reported in this paper isAF037041 and that of the mtrD gene of strain BR54 is AF037040.
peptidoglycan (Guymon et al., 1978) . These biochemical changes in the cell envelope chemistry of E~~-strains were postulated to be responsible for their enhanced permeability to HAS.
The mtr locus in N. gonorrhoeae (Maness & Sparling, for the mtrD-54 (env-3) and mtrC-87 (env-2) genes of strains BR54 and BR87, respectively, are in parentheses.
* Transformant strain WV1 was obtained using the 964 bp PCR product from the mtrD gene of strain FA19 (Fig. l) , transformant WV3 was obtained using the same 964 bp PCR product from WV2 and transformant AY1 was obtained using the PCR-amplified mtrC gene from strain FA19. Guymon & Sparling, 1975) has been recently characterized (Pan & Spratt, 1994; Hagman et af., 1995) and consists of the mtrR gene, positioned 250 bp upstream and divergently transcribed from a three-gene (mtrCDE) complex (Fig. 1) encoding cell envelope proteins that form an energy-dependent efflux pump (Lucas et af., 1995) . This efflux pump, not altered cell envelope permeability (Guymon & Sparling, 1975), appears to be responsible for the HA-resistant property exhibited by certain strains of gonococci (Pan & Spratt, 1994; Shafer et af., 1995) . Moreover, the mtr efflux system is crucial for expression of maximal levels of chromosomally mediated penicillin resistance that results from mutations at unlinked genes .
1973;
The MtrR protein appears to be a transcriptional repressor and performs a critical role in regulating transcription of the mtrCDE gene complex (Hagman et af., 1995) . Thus, mutations within the mtrR-coding region or a single base pair deletion in a 13 bp inverted repeat in its promoter enhance mtrCDE gene expression leading to elevated HA resistance . However, overexpression of the mtrCDE gene complex has a physiological consequence since it is known (Eisenstein & Sparling, 1978 ) that transformant strains bearing mtrR mutations display a slower growth rate than that of the wild-type parental strain. A possible selective advantage in uivo, in the absence of HAS (or penicillin), for strains bearing enu mutations is that the reduced growth rate imparted by mutations in mtrR can be reversed to wild-type levels by a co-resident mutation in enu-2 or enu-3 (Eisenstein & Sparling, 1978) .
Based on the deduced amino acid sequences of the MtrC-MtrD-MtrE proteins, it is clear that the mtr efflux pump in gonococci is similar to the MexAMexB-OprM pump of Pseudomonas aeruginosa and the AcrA/E-AcrB/F-TolC systems of Escherichia cofi (reviewed by Nikaido, 1994 Nikaido, ,1996 Paulsen et al., 1996) . The gonococcal MtrC protein belongs to the membrane fusion protein (MFP) family (Saier et al., 1994 ) that links the cytoplasmic-membrane MtrD transporter protein, which belongs (Hagman et af., 1997) to the resistance/ nodulation/division protein family (Saier et af., 1994) , to the MtrE outer-membrane protein. The MtrE protein probably forms an outer-membrane channel that facilitates export of HAS (Delahay et af., 1997), in a manner proposed for the TolC and OprM outer-membrane proteins of E. coli and P. aeruginosa, respectively (Nikaido, 1996) . As the mtrCDE-encoded efflux pump performs a predominant role in determining levels of gonococcal resistance to HAS, including toxic fatty acids and bile salts that bathe certain mucosal surfaces (Morse et af., 1982) , we analysed whether the Env-strains studied previously by Sarubbi et af. (1975) contain mutations in their mtrCDE gene complex. We now report that these Env-strains contain small deletions in their mtrC or mtrD genes and that these mutations are responsible for their HA-hypersusceptible trait.
METHODS
Strains of N. gonorrhoeae employed and growth conditions. Strain FA19 and a panel of isogenic transformant strains (Table 1) were kindly provided by P. F. Sparling (University of North Carolina, Chapel Hill, NC, USA). HA hypersusceptibility was defined when the MIC of erythromycin was < 0 1 2 pg ml-l and that of Triton X-100 (TX-100) was < 62 pg ml-'. All strains were propagated on GCB agar (Difco) containing glucose and iron supplements (Shafer et al., 1984) with incubation at 37 "C under 3.8 '
PCR amplification and DNA sequencing. Chromosomal DNA was prepared by the method of McAllister 8c Stephens (1993) and used in PCR amplification reactions as described pre- viously . The oligonucleotide primers used in this investigation are described in Table 2 . DNA sequencing was performed on PCR products using the cycle sequencing protocol or by automatic DNA sequencing; automatic sequencing was performed by the Nucleic Acid Core Facility of Emory University. Nucleotide and amino acid sequence analysis was performed using DNAStar.
Transformation and isolation of spontaneous mutants.
Piliated gonococci were transformed with bulk chromosomal DNA or PCR products prepared from strain FA19 essentially as described by Sarubbi et al. (1975) . Transformation experiments initially employed PCR products immediately after the amplification reaction. In subsequent experiments, products with transforming activity were purified by agarose gel electrophoresis to exclude transformation due to the input template DNA. Erythromycin-resistant transformants of strains BR54 and BR87 were selected using erythromycin at 0-12 or 0.25 pg ml-'. Transformants were scored for levels of resistance to erythromycin, penicillin G and TX-100 as described previously (Shafer et al., 1984) . Spontaneous HAresistant mutants were selected by plating suspensions onto GCB agar containing erythromycin (0-12 or 0 2 5 pg ml-l) or TX-100 (500 pg ml-').
SDSPAGE and Western blotting. Whole-cell lysates of gonococcal strains were prepared as described previously , while total cell envelope proteins were prepared as described by Clark et al. (1987 
RESULTS AND DISCUSSION
Presence of phenotypically suppressed mtrR mutations in HA-hypersusceptible transformant strains HA-hypersusceptible strains BR54 (env-3) and BR87 (env-2) were generated in P. F. Sparling's laboratory in the mid-1970s using donor DNA from HA-hypersusceptible strains FA32 (for BR54) or FA47 (for BR87) to transform HA-resistant strain FA140. T h e env-3 and env-2 mutations in strains BR54 and BR87 were postulated to occur at different sites because they recombine frequently, yielding HA-resistant transformants Eisenstein & Sparling, 1978; Shafer et al., 1984) . Sarubbi et al. (1975) found that strains BR.54 a n d BR87 could also donate high-level HA resistance to wild-type strain FA19 in these transformation experiments, suggesting that they also contain a phenotypically suppressed mutation in their mtrR gene (Pan & Spratt, 1994 . The glycine residue a t position 45 of the MtrR protein produced by strain FA19 is shown (G). The glycine-45 to aspartic acid (D) substitution within the MtrR protein produced by strains BR87 and BR54 is shown. In addition to this missense mutation, strain BR54 also contains a single base pair deletion within the 13 bp inverted repeat localized within the mtrR promoter (data not presented). The regions of the mtr operon of strain FA19 capable of transforming strains BR87 and BR54 for HA resistance are shown in the boxed regions on their respective lines. The darkened box within the mtrD gene of strain BR54 shows the region (nucleotide positions 2029-2993) mapped by transformation that contained the 10 bp deletion responsible for HA hypersusceptibility in this strain.
repressor (Pan & Spratt, 1994) . This radical amino acid substitution abrogates binding of the MtrR repressor to its target DNA sequence, the overlapping, divergent promoters used for mtrR and mtrCDE expression (Lucas et al., 1997) . Importantly, when introduced into strain FA19 by transformation, this missense mutation provided for increased HA resistance .
T o determine the nature of the phenotypically suppressed mtrR gene in strain BR54, we sequenced its mtrR gene and that of HA-resistant parental strain FA140. Using oligonucleotide primers previously employed (Table 2; to amplify the mtrR gene, we determined that the mtrR gene from strains BR54 and FA140 also contained the missense mutation in codon 45 present in BR87 (Fig. 1) but, unlike BR87, they also contained a single base pair deletion in the 13 bp inverted repeat within the promoter utilized for mtrR gene transcription . This base pair deletion in the mtrR promoter abrogates transcription of mtrR but enhances transcription from the overlapping, divergent promoter used for mtrCDE gene transcription and is sufficient to provide high-level HA resistance .
Strains BR87 and BR54 contain small deletions in their mtrC and mtrD genes, respectively
Since the HA-susceptibility profiles of strains BR54 and BR87 Table 1 ) resembled those of mutants of strain FA19 that contained insertionally inactivated mtrCDE genes (Hagman et al., , 1997 Delahay et al., 1997) , we hypothesized that the enu-2 and enu-3 mutations might reside within the mtrCDE gene complex. T o test this hypothesis, the mtrC, mtrD and mtrE genes from wild-type strain FA19 were amplified by PCR and used to transform strains BR54 and BR87 for HA resistance.
With strain BR87 (env-2) as the recipient, only the mtrCencoding sequence (obtained with oligonucleotide primers KH9#1 and mtrD#2; Table 2 ) from strain FA19 exhibited transforming activity (Fig. 1) . A representative transformant (strain AY 1) displayed enhanced resistance to TX-100 and a twofold increase in penicillin resistance. DNA sequencing of the mtrC gene from strains BR87, FA140 and AY1 was undertaken to identify the mutation(s) that might be responsible for HA hypersusceptibility in BR87. The results showed that compared to the mtrC gene from strain FA19 (GenBank accession no. U14993; Hagman et al., 1995) , the mtrC gene of strain BR87 contained a 4 bp deletion between nucleotide positions 349 and 352 and single nucleotide changes at codons 152 (GCG to G I G ) , 161 (GAA to GAG), 162 (GCA to GCG), 163 (AGC to GGC) and 390 (AAC to AAI) (Fig. 2) . All of the single nucleotide changes, but not the 4 bp deletion, were also present in parental strain FA140 (data not presented). The 4 bp deletion represents, on the mtrC-coding strand, the last four nucleotides of a six dinucleotide (GC) repeat (341-GCGCGCGCGCGC-352; underline shows deletion in BR87) and generates a new stop codon (Fig.  2) . Due to this frameshift, the MtrC protein produced by strain BR87 would be only 152 amino acids in length, diverging from the MtrC protein of strain FA19 (412 amino acids; molecular mass of 42777 Da) after amino acid position 116. The nucleotide sequence of the mtrC gene from transformant strain AY1 (Table 1) was determined and the results showed that the 4 bp deletion (Fig. 2) and each of the six point mutations described above had been repaired so as to resemble the wild-type sequence. Since the MtrC lipoprotein is a member of the MFP family (Saier et al., 1994) , it is likely that the severely truncated MtrC protein produced by BR87 is unable to interact with MtrD or MtrE or both, resulting in the loss of overall structural integrity of the mtr efflux pump.
M T GCG GCT GCG GGC GCA ACC TOT TTG M G GAG TOT TGG GCA GCQ TTC CCT
In contrast with the results obtained with BR87, only the mtrD sequence (obtained with oligonucleotide primers mtrD#l and mtrE#l; Table 2 ) from strain FA19 was able to transform strain BR54 for HA resistance (Fig. 1) .
To localize the region of the 3.2 kb mtrD gene in strain BR54 responsible for its HA-hypersusceptible property, a panel of oligonucleotide primers that would amplify overlapping regions of the mtrD gene from strain FA19 (GenBank accession no. U60099) was used to generate PCR products for transformation. With these different PCR products, the transforming activity of the mtrD sequence could be narrowed to a 964 bp fragment (obtained with oligonucleotide primers mtrD#lO and mtrD#7; Table 2 ) located near the 3'-end of the gene (shown as nucleotide positions 2029-2993 in Fig. 1) . A representative transformant (WVl) was as HA resistant as the immediate parental strain of BR54 (strain FA140; Table 1 ).
A mutation in the mtrD gene from strain BR54 was identified by sequencing the aforementioned PCR product obtained from strains FA19, BR54 and transformant strain WV1. From this analysis it was determined that compared to strains FA19, FA140 and WV1, strain BR54 contained a 10 bp deletion (5'-CGTAACCGGG-3'; nucleotide positions 2736-2745 in the mtrD gene of strain FA19), while WV1 had this deletion repaired (Fig.  3) . The 10 bp deletion would result in the production of an MtrD protein that would diverge from the wild-type sequence at amino acid position 912. Moreover, due to the introduction of a new stop codon (TGA ; nucleotides 2825-2827 in the mtrD gene of strain FA19), the MtrD protein produced by strain BR54 would contain 938 amino acids (molecular mass of 99935 Da) compared to the 1067 amino acid MtrD protein produced by strain FA19 (molecular mass of 113928 Da). Importantly, a topology model for the MtrD protein of strain FA19 has been deduced (Hagman et al., 1997) and it predicts the existence of 12 transmembrane domains, seven cytoplasmic loops and six periplasmic loops. From this model, the MtrD protein produced by BR54 would lack the last three C-terminal transmembrane domains as well as two periplasmic and cytoplasmic loops with the last 26 amino acids being located in the cytoplasm (M. Nilles, personal communication).
Isolation of spontaneous HA-resistant mutants
T o identify mutations that might reverse the effects of the small deletions in the mtrC and mtrD genes in BR87 and BR54, respectively, spontaneous HA-resistant mutants of strains BR54 and BR87 were sought. Erythromycin-resistant mutants of strain BR54 arose at a low frequency (4 x lo-') but such mutants of BR87 could not be recovered (frequency < 10-l') despite repeated efforts. A spontaneous erythromycin-resistant mutant (WV2) of BR54 displayed high-level resistance to TX-100 (MIC > 16000 pg ml-l) but resistance to erythromycin and penicillin was twofold lower than that of FA140 or WV1 (Table 1 ). The DNA sequence of the -mtrD gene from strain WV2 that could be amplified by PCR with primers mtrD#lO and mtrD#7 was determined. The results showed that an additional 2 bp had been deleted in the mtrD sequence of strain WV2 (shown in Fig. 3 with asterisks above the BR54 sequence). This 2 bp deletion in strain WV2 would restore the correct reading frame for the mtrD gene but would also result in a loss of four amino acids (Val-Thr-Gly-Arg) prior to returning to the wild-type amino acid sequence (Fig. 3 ) .
The Thr-Gly-Arg sequence represents the first three amino acids of the fifth periplasmic loop predicted to exist for MtrD (Hagman et al., 1997) , but the deletion of the Val-Thr-Gly-Arg peptide is not predicted to significantly alter the topology map of MtrD (M. Nilles, personal communication), We confirmed the importance of the 2 bp deletion in the mtrD gene sequence in WV2 by transformation. Using a PCR product containing this region, we were able to obtain transformants of strain BR54 expressing enhanced HA resistance (see WV3 in Table 1 ) similar to that observed with donor strain WV2.
Heretofore, all mutations that altered HA resistance in gonococci have mapped to the mtrR regulatory gene (mutations that enhance resistance) or were laboratoryderived insertional mutations in the mtrCDE gene complex (mutations that decrease HA resistance). Moreover, a survey of the literature suggests that all other mutations in the resistance/nodulation/division protein class of efflux pumps (Saier et af., 1994) , of which the mtr system is a member, that decrease efflux pump activity represent regulatory mutants or strains with purposeful, laboratory-derived insertional mutations. Our finding that HA-hypersusceptible transformant strains BR54 and BR87 contain small deletions in their mtrCD genes is the first report, to our knowledge, of loss-of-function-type mutations in bacterial efflux pump genes.
The findings presented in this report clarify the mechanism by which strains BR54 and BR87, the first laboratory-derived HA-hypersusceptible strains isolated in the gonococcus , exhibit HA hypersusceptibility. While it was originally thought (Guymon & Sparling, 1975 ) that these strains had increased permeability for HAS, it is now clear that their respective mtr efflux pumps are abnormal. Thus, the small deletions in the mtrC or mtrD genes in strains BR87 and BR54 would result in truncated, partially nonsensical MtrC or MtrD proteins. Since MtrC is in the family of MFPs (Saier et d., 1994) that are presumed to link the cytoplasmic-membrane efflux transporter protein to the outer-membrane protein that serves as a channel for exported antimicrobials (Nikaido, 1996) , it is likely that this function is abolished in strain BR87. We also confirmed that HA-hypersusceptible strains BR54 and BR87 contain phenotypically suppressed mutations in their nztrR gene, which is consistent with the earlier prediction of Sarubbi et al. (1975) . The mutations occur within the rntrR-coding sequence that determines the amino acid composition of the helixturn-helix domain of MtrR or in a 13 bp inverted repeat sequence that lies between the -10 and -35 regions of the mtrR promoter. When transferred to wild-type strain FA19, any of these mutations are sufficient to increase HA resistance Shafer et af., 1995) . We have evaluated two recent HA-hypersusceptible clinical isolates because the original report of Eisenstein & Sparling (1978) suggested that such strains would have both phenotypically suppressed mutations in mtrR and mutations similar to the mtrC mutation in strain BR87. We found that these two recent clinical isolates contained a single missense mutation in their mtrR-coding region that mapped to codon 40 (GCC to ACC) , causing a replacement of alanine with threonine in the helix-turn-helix region of the MtrR repressor; this replacement is sufficient to mediate increased HA resistance in gonococci . Surprisingly, however, the genetic lesion for HA hypersusceptibility in these strains appears not to map within the mtrCDE complex (data not presented). Accordingly, these recent clinical isolates, as opposed to those studied in the 1970s (Eisenstein & Sparling, 1978) , could have mutations that affect alternative efflux pumps or permeability systems or unlinked control systems that modulate mtr efflux activity. Nevertheless, the presence of phenotypically suppressed mtrR mutations in these strains and the presence of an unlinked mutation(s) that results in hypersusceptibility of gonococci to HAS is consistent with the earlier hypothesis (Shafer et al., 1984) that mtrR mutations are first seiected when gonococci are introduced into an environment bathed in HAS (such as the rectum). Subsequent secondary mutations that reverse the effect of mtrR mutations (HA resistance and slower growth rate) could arise when gonococci enter other sites that may be hostile for those slower growing gonococci harbouring mtrR mutations. The genetic basis for HA hypersusceptibility in these clinical isolates is now under investigation.
